Search research articles
Contact Us
Filters
Showing results (201-210 of 295) with videos related to
Page
of 30
Sort By:
International Journal of Cancer
|
July 23, 2011
Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis
Yoshinori Hirashima, Yasuhide Yamada, Ukihide Tateishi, et al.
Journal of Gastroenterology and Hepatology
|
August 29, 2015
Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer
Kei Muro, Sang Cheul Oh, Yasuhiro Shimada, et al.
Cancer Science
|
February 25, 2015
Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer
Naoki Takahashi, Yasuhide Yamada, Koh Furuta, et al.
Clinical Drug Investigation
|
December 28, 2020
Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial
Kensei Yamaguchi, Yasuhiro Shimada, Shuichi Hironaka, et al.
BMC Cancer
|
July 10, 2012
Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
Megumi Ishiguro, Hidetaka Mochizuki, Naohiro Tomita, et al.
Redox Biology
|
December 23, 2022
A hydrolysate of poly-trans-[(2-carboxyethyl)germasesquioxane] (Ge-132) suppresses Ca<sub>v</sub>3.2-dependent pain by sequestering exogenous and endogenous sulfide
Fumiko Sekiguchi, Nene Koike, Yasuhiro Shimada, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
December 6, 2018
Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial
Toshihiko Doi, Satoru Iwasa, Kei Muro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics
Yoshiyuki Suehara, Tadashi Kondo, Kunihiko Seki, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
August 28, 2012
Phase I/II study of radiologic hepatic arterial infusion of fluorouracil plus systemic irinotecan for unresectable hepatic metastases from colorectal cancer: Japan Clinical Oncology Group Trial 0208-DI
Yasuaki Arai, Atsushi Ohtsu, Yozo Sato, et al.
Anti-Cancer Drugs
|
June 25, 2016
Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract
Tomonori Araki, Atsuo Takashima, Tetsuya Hamaguchi, et al.
Page
of 30
Search research articles
Search
Showing results (201-210 of 295) with videos related to
Sort By:
Page
of 30
International Journal of Cancer
|
July 23, 2011
Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis
Yoshinori Hirashima, Yasuhide Yamada, Ukihide Tateishi, et al.
Journal of Gastroenterology and Hepatology
|
August 29, 2015
Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer
Kei Muro, Sang Cheul Oh, Yasuhiro Shimada, et al.
Cancer Science
|
February 25, 2015
Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer
Naoki Takahashi, Yasuhide Yamada, Koh Furuta, et al.
Clinical Drug Investigation
|
December 28, 2020
Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial
Kensei Yamaguchi, Yasuhiro Shimada, Shuichi Hironaka, et al.
BMC Cancer
|
July 10, 2012
Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
Megumi Ishiguro, Hidetaka Mochizuki, Naohiro Tomita, et al.
Redox Biology
|
December 23, 2022
A hydrolysate of poly-trans-[(2-carboxyethyl)germasesquioxane] (Ge-132) suppresses Ca<sub>v</sub>3.2-dependent pain by sequestering exogenous and endogenous sulfide
Fumiko Sekiguchi, Nene Koike, Yasuhiro Shimada, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
December 6, 2018
Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial
Toshihiko Doi, Satoru Iwasa, Kei Muro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics
Yoshiyuki Suehara, Tadashi Kondo, Kunihiko Seki, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
August 28, 2012
Phase I/II study of radiologic hepatic arterial infusion of fluorouracil plus systemic irinotecan for unresectable hepatic metastases from colorectal cancer: Japan Clinical Oncology Group Trial 0208-DI
Yasuaki Arai, Atsushi Ohtsu, Yozo Sato, et al.
Anti-Cancer Drugs
|
June 25, 2016
Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract
Tomonori Araki, Atsuo Takashima, Tetsuya Hamaguchi, et al.
Page
of 30